XCancer

PD-L1 Targeting Peptide Probe 68Ga-cPP-BCH for PET Imaging of Solid Tumor

Description:

The objective of this study is to construct a noninvasive approach using radiolabbled peptide 68Ga-cPP-BCH PET/CT to detect the PD-L1 expression of tumor lesion in patients with lung cancer, melanoma and other solid tumor to identify patients benefiting from anti-PD-(L)1 treatment.

Sponsor:

Peking University Cancer Hospital & Institute

Phase:

N/A

Contacts:

Hua Zhu (Professor)

zhuhuabch@pku.edu.cn

+86-010-88196495

Government Study Link:

NCT07442292 - Click here to see study on

ClinicalTrials.gov

68Ga-cPP-BCH

Isotope(s):
Target(s):
  • PD-L1